Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Two Key Reasons to Buy Teva Pharmaceuticals
Seeking Alpha
Monday, May 10, 2010 - 9:38am
tags:
Teva Pharmaceuticals, Copaxone, GAAP
Lexicon 1Q net loss widens on lower revenue
Yahoo/AP
Monday, May 10, 2010 - 9:26am
tags:
Lexicon Pharmaceuticals, earnings
J&J Drug Recall Is a Minor Blip: Poll Says
TheStreet.com
Monday, May 10, 2010 - 9:22am
tags:
JNJ, recalls
Avexa Plunges 75% After Scrapping Most Advanced Drug
Bloomberg
Monday, May 10, 2010 - 9:21am
tags:
HIV, Avexa
Ariad's New Deal With Merck Refills Its Coffers
Seeking Alpha
Monday, May 10, 2010 - 9:21am
tags:
Merck, Ariad Pharmaceuticals, partnerships, ridaforolimus
Biotech's Latest Business Mishaps
Seeking Alpha
Monday, May 10, 2010 - 9:19am
tags:
Abbott Laboratories, Bristol-Myers Squibb, GSK, InterMune, JNJ, Merck, Pfizer, Newron Pharma, Dainippon Sumitomo
Q1 Results, Healthcare Reforms Provide Pharma Opportunity to Downplay Expectations
Seeking Alpha
Monday, May 10, 2010 - 9:17am
tags:
earnings, Abbott Laboratories, Amgen, Eli Lilly, Merck, Pfizer, Sanofi
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Sunday, May 9, 2010 - 12:49pm
tags:
Bydureon, Amylin, Eli Lilly, Alkermes, type 2 diabetes
Savient Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
Seeking Alpha
Sunday, May 9, 2010 - 12:11pm
tags:
Savient, earnings
Obagi Medical Products, Inc. Q1 2010 Earnings Call Transcript
Seeking Alpha
Sunday, May 9, 2010 - 12:10pm
tags:
Obagi Medical Products, earnings
Sanofi Takes Issue With Canada's Bias for Generics
Seeking Alpha
Sunday, May 9, 2010 - 12:08pm
tags:
Sanofi, Canada, generics
GlaxoSmithKline On FDA's Rotavirus Vaccine Concerns
Forbes
Sunday, May 9, 2010 - 12:06pm
tags:
GSK, rotavirus, Rotarix, FDA
XOMA Ltd. Q1 2010 Earnings Call Transcript
Seeking Alpha
Saturday, May 8, 2010 - 10:15am
tags:
Xoma, earnings
Health Discovery Corporation Announces Suit by Large Shareholder Seeking Declaratory Judgment Regarding Termination Date of Warrants Held by Shareholder
Yahoo/BusinessWire
Saturday, May 8, 2010 - 10:14am
tags:
Health Discovery, legal
Hemispherx Biopharma, Inc. 1st Quarter 2010 Financial Results
Yahoo/Globe NewsWire
Saturday, May 8, 2010 - 10:13am
tags:
Hemispherx, earnings
Osiris Therapeutics 1Q profit, expenses shrink
Yahoo/AP
Saturday, May 8, 2010 - 10:12am
tags:
Osiris Therapeutics, earnings
FDA's Risk Aversion Is Endangering Children
Forbes
Saturday, May 8, 2010 - 10:11am
tags:
GSK, Rotarix, rotavirus
GSK Statement on FDA Advisory Committee Meeting on Rotavirus Vaccines
Yahoo/PR NewsWire
Saturday, May 8, 2010 - 10:09am
tags:
GSK, rotavirus
FDA Accepts Novartis Vaccines' sBLA to Expand Indication of Menveo(R) to Children 2-10 Years of Age
Yahoo/MarketWire
Saturday, May 8, 2010 - 10:07am
tags:
Novartis, bacterial meningitis, Menveo
A Star-Crossed Investment
Motley Fool
Saturday, May 8, 2010 - 10:05am
tags:
Genzyme

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.